PMID- 10420388 OWN - NLM STAT- MEDLINE DCOM- 19991013 LR - 20191103 IS - 0379-0355 (Print) IS - 0379-0355 (Linking) VI - 21 IP - 5 DP - 1999 Jun TI - Effects of Cerebrolysin on in vitro primary microglial and astrocyte rat cell cultures. PG - 331-8 AB - In recent years the potential use of neurotrophic factors in the prevention and/or treatment of neurodegenerative diseases has received much attention. To determine whether Cerebrolysin, a porcine brain-derived peptide preparation, was able to modulate in vitro lipopolysaccharide (LPS)-induced microglial activation and to test the direct effect of Cerebrolysin on astrocyte morphology, survival and proliferation, rat glial and astrocyte cell culture experiments were carried out. The morphology of microglia, ameboid/activated and flat/resting, was examined under contrast microscopy and cell counts obtained. In addition, the release of interleukin (IL)-1 beta and brain-derived neurotrophic factor (BDNF) was measured from cell culture supernatant using an enzyme-linked-immunoassay (ELISA). The results obtained in this study clearly suggest a protective effect of Cerebrolysin as revealed by downregulation of microglial activation after LPS treatment as well as by the control of IL-1 beta expression. No significant differences were observed on astrocyte morphology, survival or the production and/or release of BDNF. In conclusion, these in vitro studies indicate that Cerebrolysin might exert a neuroimmunotrophic function which can in turn reduce the extent of inflammation and accelerate neuronal death under pathological conditions such as human neurodegenerative disorders. FAU - Lombardi, V R AU - Lombardi VR AD - Biotechnology Division, EuroEspes, Basic and Clinical Neurosciences Research Center, La Coruna, Spain. euroespes@lcg.servicom.es FAU - Windisch, M AU - Windisch M FAU - Garcia, M AU - Garcia M FAU - Cacabelos, R AU - Cacabelos R LA - eng PT - Journal Article PL - Spain TA - Methods Find Exp Clin Pharmacol JT - Methods and findings in experimental and clinical pharmacology JID - 7909595 RN - 0 (Amino Acids) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Interleukin-1) RN - 0 (Nootropic Agents) RN - 37KZM6S21G (cerebrolysin) SB - IM MH - Amino Acids/*pharmacology MH - Animals MH - Astrocytes/*drug effects MH - Brain-Derived Neurotrophic Factor/metabolism MH - Cell Count MH - Cell Separation MH - Cells, Cultured MH - Immunohistochemistry MH - Interleukin-1/metabolism MH - Microglia/*drug effects MH - Nootropic Agents/*pharmacology MH - Rats MH - Rats, Sprague-Dawley MH - Swine EDAT- 1999/07/27 00:00 MHDA- 1999/07/27 00:01 CRDT- 1999/07/27 00:00 PHST- 1999/07/27 00:00 [pubmed] PHST- 1999/07/27 00:01 [medline] PHST- 1999/07/27 00:00 [entrez] AID - 541910 [pii] AID - 10.1358/mf.1999.21.5.541910 [doi] PST - ppublish SO - Methods Find Exp Clin Pharmacol. 1999 Jun;21(5):331-8. doi: 10.1358/mf.1999.21.5.541910.